Abstract:
The invention relates to a trialkyl sulfonium chloride, compositions comprising the trialkyl sulfonium chloride, agricultural compositions comprising such compositions and trialkyl sulfonium chloride, respectively, to the use of the trialkyl sulfonium chloride and of the compositions as a pesticide, preferably as a fungicide, and to methods for controlling or combating pests and/or improving plant health by means of the trialkyl sulfonium chloride and compositions.
Abstract:
An elastomeric isolator is described comprising a layer of an elastomeric material, wherein the layer of elastomeric material is provided with a reinforcing material layer in the form of a graphene layer.
Abstract:
A scattering device 10 is described comprising a plurality of dipoles 20, each comprising a rod and a pair of plates 12, 22, the plates 12, 22 being located at the respective ends of the rod, the rods of the dipoles 20 being connected to one another and arranged such that the rods are angled relative to one another.
Abstract:
A reinforced concrete material is described comprising a cementitious material (22) in which graphene is substantially uniformly distributed. A method of production of concrete is also described comprising the steps of forming a substantially uniform suspension (20) of graphene with water, and mixing the suspension (20) with a cementitious material (22) to form a concrete material (28).
Abstract:
A construction block (10) is described, comprising an input wall (16) and an output wall (22) spaced apart from the input wall (16), a void (32) being formed between the input wall (16) and the output wall (22), wherein the input wall (16) has a plurality of projections (18) formed integrally therewith, the projections (18) extending toward but stopping short of the output wall (22) and serving to disrupt convection currents forming in the void (32), at least one of the projections (18) comprising a solar concentrator which has a photovoltaic device (28) mounted thereon.
Abstract:
A probe (10) comprising a body portion (70) and a tip portion (80). The body portion comprises: a first mounting portion (72) comprising a plurality of first carriers supporting elongate first waveguides, and disposed in an equiangular arrangement around a longitudinal axis (A) of the body portion; a body end fitting (74) at which first ends of the first waveguides are supported such that the first waveguides can transmit electromagnetic radiation signals from an energy source to the body end fitting and/or transmit electromagnetic radiation signals from the body end fitting to a receiver. The tip portion comprises: a second mounting portion (82) comprising a plurality of second carriers supporting elongate second waveguides, the second carriers being disposed in the equiangular arrangement around a longitudinal axis of the tip portion; and a tip end fitting (88) at which first ends of the second waveguides are supported in the equiangular arrangement around the longitudinal axis of the tip portion; and an elongate conduit (12) for piercing human tissue.
Abstract:
The invention relates to a combination comprising(i) a compound A comprising a mitochondrial targeting group linked to a group capable of releasing hydrogen sulfide or a pharmaceutically acceptable salt thereof or a prodrug thereof, an inhibitor of the thioredoxin antioxidant system or a pharmaceutically acceptable salt thereof or a prodrug thereof, and/or a nitroxide or a pharmaceutically acceptable salt thereof or a prodrug thereof; and (ii) a photosensitizer or photosensitizer precursor; for use in photodynamic therapy.
Abstract:
There is provided a NetB epitope polypeptide comprising at least 10 contiguous amino acids from SEQ ID NO:1 and comprising a mutation in at least one position between amino acids 130 and 297 as compared with the equivalent position in SEQ ID NO:3, the mutation preferably being located within a rim domain, the polypeptide being capable of binding an antibody which binds to SEQ ID NO:1 and having reduced toxicity compared with the toxicity of SEQ ID NO:1. The polypeptide is useful to vaccinate a subject against infection by Clostridium perfringens.
Abstract translation:提供了包含SEQ ID NO:1的至少10个连续氨基酸的NetB表位多肽,并且与SEQ ID NO:3中的等同位置相比,在氨基酸130和297之间的至少一个位置具有突变,突变 优选地位于边缘结构域内,所述多肽能够结合与SEQ ID NO:1结合的抗体,并且与SEQ ID NO:1的毒性相比具有降低的毒性。 该多肽可用于使受试者免疫产气荚膜梭菌感染。
Abstract:
There is provided an epsilon toxin epitope polypeptide comprising a sequence of at least 10 contiguous amino acids from SEQ ID NO:3, the sequence comprising a mutation of at least one tyrosine residue compared to the equivalent sequence in SEQ ID NO:3, the polypeptide being capable of binding an antibody which binds to SEQ ID NO:5 and having reduced toxicity compared with the toxicity of SEQ ID NO:5. The polypeptide is useful in a method of vaccinating a subject against developing a disease caused by clostridium perfringens and/or caused by (or associated with the presence of) active epsilon toxin.
Abstract translation:提供了包含SEQ ID NO:3的至少10个连续氨基酸的序列的ε-毒素表位多肽,所述序列包含与SEQ ID NO:3中的等同序列相比至少一个酪氨酸残基的突变,所述多肽 能够结合与SEQ ID NO:5结合的抗体,并且与SEQ ID NO:5的毒性相比具有降低的毒性。 该多肽可用于接种受试者以发展由产气荚膜梭菌引起的疾病和/或由活性ε毒素(或与其存在)引起的疾病接种的方法。
Abstract:
There is provided a NetB epitope polypeptide comprising at least 10 contiguous amino acids from SEQ ID NO:1 and comprising a mutation in at least one position between amino acids 130 and 297 as compared with the equivalent position in SEQ ID NO:3, the mutation preferably being located within a rim domain, the polypeptide being capable of binding an antibody which binds to SEQ ID NO:1 and having reduced toxicity compared with the toxicity of SEQ ID NO:1. The polypeptide is useful to vaccinate a subject against infection by Clostridium perfringens.
Abstract translation:提供了包含SEQ ID NO:1的至少10个连续氨基酸的NetB表位多肽,并且与SEQ ID NO:3中的等同位置相比,在氨基酸130和297之间的至少一个位置具有突变,突变 优选地位于边缘结构域内,所述多肽能够结合与SEQ ID NO:1结合的抗体,并且与SEQ ID NO:1的毒性相比具有降低的毒性。 该多肽可用于使受试者免疫产气荚膜梭菌感染。